Alexey L. Margolin is Chief Scientific Officer at Altus Pharmaceuticals Inc. (ALTU). They have made 2 open-market trades across 1 company since 2006, most recently 2007-07-18.
CIK 0001350080
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ALTU | 135,204 | $1.4M |
Shares reported on the most recent Form 4, priced at the 2007-07-20 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ALTU | SELL · 10b5-1 | 2007-07-18 | 2007-07-20 | $11.55 | $126K | +3.2% | +0.7% | +0.7% |
| ALTU | SELL · 10b5-1 | 2007-04-02 | 2007-04-03 | $14.94 | $47K | +3.2% | +0.7% | +0.7% |
| ALTU | SELL · 10b5-1 | 2007-03-22 | 2007-03-26 | $16.00 | $50K | +3.2% | +0.7% | +0.7% |
| ALTU | SELL · 10b5-1 | 2007-03-19 | 2007-03-19 | $14.88 | $47K | +3.2% | +0.7% | +0.7% |
| ALTU | SELL · 10b5-1 | 2007-03-05 | 2007-03-06 | $14.19 | $44K | +3.2% | +0.7% | +0.7% |
| ALTU | SELL · 10b5-1 | 2007-02-20 | 2007-02-21 | $17.36 | $109K | +3.2% | +0.7% | +0.7% |
| ALTU | SELL · 10b5-1 | 2007-02-05 | 2007-02-06 | $18.12 | $113K | +3.2% | +0.7% | +0.7% |
| ALTU | SELL · 10b5-1 | 2007-01-22 | 2007-01-22 | $18.73 | $117K | +3.2% | +0.7% | +0.7% |
| ALTU | SELL · 10b5-1 | 2007-01-08 | 2007-01-09 | $19.40 | $121K | +3.2% | +0.7% | +0.7% |
| ALTU | SELL · 10b5-1 | 2006-12-27 | 2006-12-28 | $19.77 | $124K | +3.2% | +0.7% | +0.7% |
| ALTU | SELL · 10b5-1 | 2006-12-11 | 2006-12-12 | $19.21 | $120K | +3.2% | +0.7% | +0.7% |
| ALTU | SELL · 10b5-1 | 2006-11-27 | 2006-11-28 | $18.01 | $113K | +3.2% | +0.7% | +0.7% |
| ALTU | SELL | 2006-11-13 | 2006-11-15 | $16.94 | $114K | +3.2% | +0.7% | +0.7% |
| ALTU | SELL | 2006-11-13 | 2006-11-15 | $16.68 | $18K | +3.2% | +0.7% | +0.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.